Literature DB >> 29896677

Encyclopedia of EBV-Encoded Lytic Genes: An Update.

Takayuki Murata1,2.   

Abstract

In addition to latent genes, lytic genes of EBV must also be of extreme significance since propagation of the virus can be achieved only through execution of lytic cycle. Research on EBV lytic genes may thus prevent spreading of the virus and alleviate disorders, such as infectious mononucleosis and oral hairy leukoplakia, which are highly associated with EBV lytic infection. Moreover, recent advancements have been demonstrating that at least several lytic genes are expressed to some extent even during latent state. It is also demonstrated now that upon de novo infection, EBV expresses lytic genes in addition to latent genes before establishment of latency (this phase is called "pre-latent abortive lytic state"). In those cases, lytic genes also play important roles in cell proliferation of EBV-positive cells. However, many lytic gene products have not been identified yet nor studied thoroughly, and even worse, some have been misidentified in the literature. Here, I would like to give a detailed up-to-date review on EBV lytic genes.

Entities:  

Keywords:  Assembly; Capsid; EBV; Epstein-Barr virus; Gene expression; Glycoprotein; Replication; Tegument

Mesh:

Substances:

Year:  2018        PMID: 29896677     DOI: 10.1007/978-981-10-7230-7_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Pharmacologic Activation of Lytic Epstein-Barr Virus Gene Expression without Virion Production.

Authors:  Jaeyeun Lee; John G Kosowicz; S Diane Hayward; Prashant Desai; Jennifer Stone; Jae Myun Lee; Jun O Liu; Richard F Ambinder
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 2.  The lytic phase of Epstein-Barr virus plays an important role in tumorigenesis.

Authors:  Yue Liang; Yan Zhang; Bing Luo
Journal:  Virus Genes       Date:  2022-10-15       Impact factor: 2.198

3.  Initial Characterization of the Epstein⁻Barr Virus BSRF1 Gene Product.

Authors:  Yusuke Yanagi; H M Abdullah Al Masud; Takahiro Watanabe; Yoshitaka Sato; Fumi Goshima; Hiroshi Kimura; Takayuki Murata
Journal:  Viruses       Date:  2019-03-21       Impact factor: 5.048

Review 4.  Molecular Basis of Epstein-Barr Virus Latency Establishment and Lytic Reactivation.

Authors:  Takayuki Murata; Atsuko Sugimoto; Tomoki Inagaki; Yusuke Yanagi; Takahiro Watanabe; Yoshitaka Sato; Hiroshi Kimura
Journal:  Viruses       Date:  2021-11-23       Impact factor: 5.048

5.  Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.

Authors:  Ute-Christiane Meier; Richard Christopher Cipian; Abbas Karimi; Ranjan Ramasamy; Jaap Michiel Middeldorp
Journal:  Front Immunol       Date:  2021-11-01       Impact factor: 7.561

6.  EBV Exploits RNA m6A Modification to Promote Cell Survival and Progeny Virus Production During Lytic Cycle.

Authors:  Yusuke Yanagi; Takahiro Watanabe; Yuya Hara; Yoshitaka Sato; Hiroshi Kimura; Takayuki Murata
Journal:  Front Microbiol       Date:  2022-06-15       Impact factor: 6.064

7.  Epstein-Barr Virus BBRF2 Is Required for Maximum Infectivity.

Authors:  H M Abdullah Al Masud; Yusuke Yanagi; Takahiro Watanabe; Yoshitaka Sato; Hiroshi Kimura; Takayuki Murata
Journal:  Microorganisms       Date:  2019-12-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.